Alliancebernstein L.P. Lian Bio Transaction History

Alliancebernstein L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.15 - $6.01 $3.24 Million - $9.06 Million	-1,507,469 Reduced 99.24%	11,500 $25,000
Q1 2022 May 13, 2022	SELL	$2.8 - $6.21 $4.72 Million - $10.5 Million	-1,685,761 Reduced 52.6%	1,518,969 $5.64 Million
Q4 2021 Feb 14, 2022	BUY	$6.14 - $16.2 $19.7 Million - $51.9 Million	3,204,730 New	3,204,730 $19.7 Million

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.